FDA 483 - Hansen Mueller Company Kansas City - May 03, 2024

An FDA inspection of Hansen Mueller Company Kansas City, a warehouse, revealed critical deficiencies in preventing cross-contamination between mammalian and non-mammalian derived protein products. The firm failed to implement adequate cleanout procedures, properly label products with required caution statements, and ensure employees were trained on product separation and BSE. Additionally, equipment was not cleaned and maintained to prevent contamination, with observed insect and mold buildup.